Answers are grounded in this paper and cite their sources.
Demonstrates improved TB diagnosis in Africa, indicating a need for modern testing technologies.
In 2024, there were an estimated 2·6 million people with TB in Africa, and approximately a quarter of these were not registered as having started treatment.1 The gap has persisted and been compounded by the low uptake of new rapid diagnostics recommended by the World Health Organization (WHO) – in the same year, only 53% of notified cases were tested with these modern technologies in Africa. The other half have relied on outdated smear microscopy. In fact, access remains the biggest barrier, with only 8 of the 30 high-burden TB countries globally reporting that at least half of their diagnostic sites have a WHO-recommended rapid diagnostic available.
No takes yet. Share an insight, caveat, or question.
Ismail et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: